Catalyst Financial Partners’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Hold |
38,457
| – | – | 0.02% | 299 |
|
|
2025
Q1 | $146K | Hold |
38,457
| – | – | 0.03% | 283 |
|
|
2024
Q4 | $209K | Hold |
38,457
| – | – | 0.04% | 265 |
|
|
2024
Q3 | $161K | Hold |
38,457
| – | – | 0.03% | 272 |
|
|
2024
Q2 | $113K | Buy |
38,457
+2,190
| +6% | +$6.46K | 0.02% | 245 |
|
|
2024
Q1 | $94.3K | Hold |
36,267
| – | – | 0.02% | 226 |
|
|
2023
Q4 | $103K | Hold |
36,267
| – | – | 0.03% | 215 |
|
|
2023
Q3 | $93.6K | Hold |
36,267
| – | – | 0.03% | 205 |
|
|
2023
Q2 | $157K | Buy |
36,267
+11,157
| +44% | +$48.2K | 0.06% | 198 |
|
|
2023
Q1 | $38.4K | Buy |
25,110
+10,635
| +73% | +$16.3K | 0.02% | 180 |
|
|
2022
Q4 | $22.9K | Buy |
+14,475
| New | +$22.9K | 0.01% | 161 |
|